These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38962322)

  • 1. Molecular characterization of carbapenem and ceftazidime-avibactam-resistant Enterobacterales and horizontal spread of
    Sobh G; Araj GF; Finianos M; Sourenian T; Hrabak J; Pappagianitsis CC; Chaar ME; Bitar I
    Front Cell Infect Microbiol; 2024; 14():1407246. PubMed ID: 38962322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli.
    Öztaş S; Er DK; Dündar D; Keçeli SA
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):110-120. PubMed ID: 38837219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values.
    Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE
    Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of ceftazidime-avibactam resistance in bla
    Zhou J; Yan G; Tang C; Liu J; Fu P; Ding L; Yang W; Guo Y; Wang C; Lu G; Hu F
    Int J Antimicrob Agents; 2024 Jun; 63(6):107163. PubMed ID: 38570018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring
    Niu S; Chavda KD; Wei J; Zou C; Marshall SH; Dhawan P; Wang D; Bonomo RA; Kreiswirth BN; Chen L
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime-Avibactam Resistance Associated with Increased
    Coppi M; Di Pilato V; Monaco F; Giani T; Conaldi PG; Rossolini GM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spreading Patterns of NDM-Producing
    Sugawara Y; Akeda Y; Hagiya H; Sakamoto N; Takeuchi D; Shanmugakani RK; Motooka D; Nishi I; Zin KN; Aye MM; Myint T; Tomono K; Hamada S
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis.
    Krithika VM; Ganesan V; Rajendran T
    Indian J Med Microbiol; 2024; 49():100603. PubMed ID: 38705276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of a Stable and Transferable
    Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B
    Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms Driving the
    Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
    mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals.
    Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS
    Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant
    Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F
    mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.
    Venditti C; Butera O; Meledandri M; Balice MP; Cocciolillo GC; Fontana C; D'Arezzo S; De Giuli C; Antonini M; Capone A; Messina F; Nisii C; Di Caro A
    Clin Microbiol Infect; 2021 Jul; 27(7):1040.e1-1040.e6. PubMed ID: 33775814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole genome sequencing analysis of seven unknown resistance mechanisms of carbapenem-resistant Klebsiella pneumoniae strains resistance to ceftazidime-avibactam.
    Chen Y; Huang J; Chen H; Xiao H; Shen X; Chen Q; Zhang Z; Huang Y; Wu S; Chen D
    J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of the
    Tian D; Wang B; Zhang H; Pan F; Wang C; Shi Y; Sun Y
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31915216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS.
    Pérez-Vázquez M; Sola Campoy PJ; Ortega A; Bautista V; Monzón S; Ruiz-Carrascoso G; Mingorance J; González-Barberá EM; Gimeno C; Aracil B; Sáez D; Lara N; Fernández S; González-López JJ; Campos J; Kingsley RA; Dougan G; Oteo-Iglesias J;
    J Antimicrob Chemother; 2019 Dec; 74(12):3489-3496. PubMed ID: 31504589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant
    Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q
    Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates.
    Benulič K; Pirš M; Couto N; Chlebowicz M; Rossen JWA; Zorec TM; Seme K; Poljak M; Lejko Zupanc T; Ružić-Sabljić E; Cerar T
    PLoS One; 2020; 15(4):e0231503. PubMed ID: 32282829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.